TAS2R19 Antibody

What is TAS2R19 and what is its functional role?

TAS2R19 (also known as Taste Receptor Type 2 Member 48, TAS2R48, T2R19, T2R23, or T2R48) is a G protein-coupled receptor that plays a critical role in the perception of bitter taste. This receptor belongs to the T2R family of bitter taste receptors and may recognize specific bitter compounds . These receptors function by initiating signaling cascades upon detection of bitter compounds, ultimately leading to taste perception. Beyond taste perception, emerging research suggests potential roles for bitter taste receptors in other physiological processes, including possible associations with certain cancers as suggested by ongoing research .

What are the key specifications to consider when selecting a TAS2R19 antibody?

When selecting a TAS2R19 antibody for research, several critical specifications must be considered:

• Target specificity: Ensure the antibody specifically recognizes TAS2R19, ideally with validation against endogenous levels of the target protein

• Binding region: Different antibodies may target different regions (e.g., internal region, N-terminus, C-terminus), which can affect detection efficacy depending on protein conformation and experimental conditions

• Species reactivity: Verify compatibility with your experimental model (e.g., human, mouse). Many TAS2R19 antibodies are specifically developed for human samples

• Host species and clonality: Consider whether a polyclonal or monoclonal antibody suits your research needs, and ensure the host species (e.g., rabbit) doesn't conflict with other reagents in your protocol

• Validated applications: Confirm the antibody has been validated for your intended applications (Western blotting, ELISA, immunocytochemistry, or immunofluorescence)

How can I validate the specificity of my TAS2R19 antibody?

Antibody validation is critical for ensuring experimental reliability. For TAS2R19 antibody validation:

• Positive control samples: Use cell lines or tissues known to express TAS2R19

• Western blot analysis: Look for a single band at the expected molecular weight

• Peptide competition assay: Pre-incubate the antibody with the immunizing peptide derived from human TAS2R48, which should eliminate or substantially reduce signal if the antibody is specific

• Knockout/knockdown controls: Compare staining in samples with reduced or eliminated TAS2R19 expression

• Cross-reactivity testing: Ensure the antibody doesn't detect related taste receptors by testing against recombinant proteins of other TAS2R family members

Proper validation should include multiple complementary techniques to confirm specificity before proceeding with critical experiments.

What are the optimal conditions for Western blotting using TAS2R19 antibodies?

For successful Western blotting with TAS2R19 antibodies:

• Sample preparation: Use appropriate lysis buffers with protease inhibitors to prevent degradation

• Antibody dilution: Start with the recommended 1:500-1:1000 dilution range for primary antibody incubation

• Blocking conditions: Use 5% non-fat milk or BSA in TBST

• Incubation time and temperature: Typically overnight at 4°C for primary antibody

• Detection system: Compatible secondary antibodies conjugated to HRP or fluorophores

• Membrane type: PVDF membranes generally provide better results for membrane proteins like TAS2R19

Since TAS2R19 is a membrane protein, ensure samples are not boiled for extended periods, as this can cause aggregation. Include positive controls, and optimize washing steps to minimize background while preserving specific signals.

How should I optimize immunofluorescence protocols for TAS2R19 detection?

For optimal immunofluorescence detection of TAS2R19:

• Fixation: Use 4% paraformaldehyde for 15-20 minutes, as over-fixation can mask epitopes

• Permeabilization: Gentle permeabilization with 0.1-0.2% Triton X-100 for 5-10 minutes

• Antibody dilution: Begin with 1:100-1:500 dilution as recommended

• Controls for membrane localization: Consider performing staining before and after permeabilization to distinguish between surface and intracellular expression, as demonstrated in taste receptor studies

• Blocking: Thorough blocking (1-2 hours) with serum matching the species of the secondary antibody

• Antibody incubation: Overnight at 4°C for primary antibody

• Counterstaining: Include membrane markers (e.g., WGA) and nuclear stains (e.g., DAPI)

When analyzing results, pay particular attention to membrane localization, as functional taste receptors should be present at the cell surface. Research has shown that some taste receptors may not reach the cell surface efficiently in heterologous expression systems, affecting functional studies .

What is the best approach for quantifying TAS2R19 in biological samples?

For quantitative assessment of TAS2R19 levels, the sandwich ELISA approach offers high sensitivity and specificity:

• Sample preparation: Process samples (serum, plasma, cell culture supernatants) according to the kit manufacturer's recommendations

• ELISA workflow:

  • Samples are applied to microplates pre-coated with TAS2R19-specific antibody

  • TAS2R19 present in samples binds to the immobilized antibody

  • A biotin-conjugated detection antibody specific for TAS2R19 is added

  • Streptavidin-HRP binds to the biotin-conjugated antibody

  • A substrate solution produces color proportional to TAS2R19 concentration

  • Color development is stopped and measured spectrophotometrically

• Standard curve generation: Prepare a dilution series of recombinant TAS2R19 standards

• Data analysis: Interpolate sample concentrations from the standard curve

This method provides quantitative data on TAS2R19 expression levels across different samples, enabling comparative studies with statistical significance.

How can I assess the cellular localization of TAS2R19 in heterologous expression systems?

Investigating cellular localization of TAS2R19 requires careful experimental design:

• Epitope tagging: Add epitope tags (e.g., Rho-tag) to the N-terminus of TAS2R19 to facilitate detection without interfering with function

• Differential staining approaches:

  • Surface localization: Stain non-permeabilized cells to detect only surface-expressed receptors

  • Total expression: Stain after permeabilization to detect all expressed receptors

• Microscopy techniques: Confocal microscopy provides superior resolution for membrane localization studies

• Co-localization markers: Include markers for different cellular compartments (plasma membrane, ER, Golgi) to determine trafficking patterns

• Live-cell imaging: Consider fluorescent protein fusions for real-time trafficking studies

This approach allows researchers to determine whether receptor trafficking defects might impact functional studies. As demonstrated in mouse taste receptor studies, some receptors fail to reach the cell surface efficiently, potentially explaining difficulties in identifying their ligands .

What strategies can be used to investigate TAS2R19 expression across different tissues?

For comprehensive expression profiling of TAS2R19:

• Quantitative RT-PCR: Design primers specific to TAS2R19, avoiding cross-reactivity with other TAS2R family members

• In situ hybridization: Develop specific RNA probes to visualize expression patterns in tissue sections

• Immunohistochemistry: Use validated TAS2R19 antibodies on tissue microarrays

• Single-cell RNA sequencing: Identify cell populations expressing TAS2R19 with higher resolution

• Comparative analysis: Compare expression levels across different tissues using a combination of methods

When interpreting results, consider that:

• Expression levels determined by qRT-PCR should correlate with protein detection by immunological methods

• Low mRNA levels typically correspond to fewer cells staining positive in in situ hybridization, as observed in taste receptor studies

• Expression may vary significantly between tissues, requiring appropriate normalization strategies

How do I design functional assays to identify agonists or antagonists of TAS2R19?

Functional characterization of TAS2R19 requires specialized assays:

• Heterologous expression systems:

  • HEK293 cells transiently transfected with TAS2R19

  • Include necessary signaling components (e.g., G proteins)

• Functional readouts:

  • Calcium imaging to detect intracellular calcium release upon receptor activation

  • FLIPR (Fluorescent Imaging Plate Reader) for high-throughput screening

  • cAMP assays to measure changes in second messenger levels

• Compound libraries:

  • Start with known bitter compounds, particularly those activating related TAS2R receptors

  • Include natural product extracts as potential sources of novel ligands

• Controls:

  • Empty vector controls to account for endogenous responses

  • Positive control receptors with known ligands

• Data analysis:

  • Determine threshold concentrations, EC50 values, and efficacy parameters

  • Compare the pharmacological profile with related receptors

When analyzing results, consider that some taste receptors may have specialized functions with narrow ligand profiles, while others may be broadly tuned to multiple compounds .

What methods can be used to compare the expression of TAS2R19 with other taste receptors?

Comparative expression analysis requires carefully controlled experiments:

• Multiplex qRT-PCR: Design primer sets with similar efficiencies for multiple taste receptors

• RNA-Seq analysis: Provides comprehensive transcriptome data for entire receptor families

• Multiplex in situ hybridization: Use differentially labeled probes to visualize expression patterns of multiple receptors in the same tissue section

• Protein-level comparison: Immunoblotting or immunostaining with validated antibodies against different taste receptors

• Reporter gene assays: Promoter activity studies to understand transcriptional regulation differences

Table of comparative expression patterns from mouse taste receptor studies illustrates how such data might be organized:

This table demonstrates how comparative analysis of surface expression (before permeabilization) versus total expression (after permeabilization) can reveal trafficking differences between receptor family members.

How can I investigate post-translational modifications of TAS2R19?

Post-translational modifications can significantly impact receptor function and trafficking:

• Phosphorylation analysis:

  • Immunoprecipitate TAS2R19 and probe with phospho-specific antibodies

  • Use phosphatase treatments to confirm specificity

  • Mass spectrometry to identify specific modified residues

• Glycosylation studies:

  • Enzymatic deglycosylation (PNGase F, Endo H) followed by Western blotting

  • Lectin binding assays to characterize glycan structures

  • Site-directed mutagenesis of predicted glycosylation sites

• Lipid modifications:

  • Metabolic labeling with radiolabeled lipid precursors

  • Click chemistry approaches for detection of palmitoylation

  • Inhibitor studies (e.g., 2-bromopalmitate) to assess functional impact

• Ubiquitination analysis:

  • Co-immunoprecipitation with ubiquitin antibodies

  • Proteasome inhibitor treatments to accumulate modified forms

  • Mass spectrometry for site identification

These studies can provide insights into regulatory mechanisms affecting receptor function and turnover, potentially explaining differences in response profiles between individuals or experimental conditions.

What are the most common pitfalls when working with TAS2R19 antibodies and how can they be addressed?

Common challenges and their solutions include:

• Non-specific binding:

  • Increase blocking time and concentration

  • Titrate antibody to optimal concentration (1:500-1:1000 for WB, 1:100-1:500 for IF/ICC)

  • Pre-absorb antibody with non-specific proteins

  • Include appropriate controls (secondary-only, isotype controls)

• Weak or no signal:

  • Verify target expression in positive control samples

  • Optimize antibody incubation conditions (time, temperature)

  • Try different epitope retrieval methods for fixed tissues

  • Consider different detection systems with higher sensitivity

• Membrane protein-specific issues:

  • Use appropriate detergents for efficient extraction

  • Avoid excessive heating that can cause aggregation

  • Consider native conditions for conformational epitopes

• Reproducibility problems:

  • Standardize sample preparation procedures

  • Use consistent lot numbers of antibodies when possible

  • Document detailed protocols including all reagents and conditions

• Storage and handling issues:

  • Store according to manufacturer recommendations (-20°C with 50% glycerol)

  • Avoid repeated freeze-thaw cycles

  • Prepare working aliquots to preserve antibody integrity

How can I distinguish between TAS2R19 and closely related taste receptors?

Differentiating between similar receptors requires careful experimental design:

• Antibody selection:

  • Choose antibodies raised against unique regions that differ between family members

  • Validate specificity using overexpression systems for each related receptor

• PCR-based approaches:

  • Design primers targeting distinctive regions, often in untranslated regions

  • Validate primer specificity against plasmids containing each receptor

  • Use high-stringency conditions to prevent cross-amplification

• RNA interference:

  • Design siRNAs targeting unique sequences

  • Validate knockdown specificity by measuring expression of related receptors

• Functional discrimination:

  • Identify compounds that selectively activate each receptor

  • Use these selective agonists as pharmacological tools

• Sequence analysis:

  • Perform detailed sequence alignments to identify distinguishing features

  • Target these regions for specific detection methods

This differentiation is critical since TAS2R19 shares similarities with other taste receptors and has alternative designations (TAS2R48, TAS2R23) that can cause confusion in the literature .

What are the emerging applications of TAS2R19 research beyond taste perception?

Recent research suggests broader roles for bitter taste receptors:

• Potential cancer associations:

  • Emerging evidence suggests connections between taste receptors and certain cancer types

  • Expression profiling in tumor vs. normal tissues

  • Functional studies examining effects on cell proliferation, migration, and apoptosis

• Immune system interactions:

  • Investigation of TAS2R expression in immune cells

  • Potential roles in detecting bacterial quorum sensing molecules

  • Signaling pathways connecting taste receptor activation to immune responses

• Metabolic regulation:

  • Expression analysis in metabolic tissues

  • Functional studies examining effects on hormone secretion

  • Potential connections to nutrient sensing networks

• Pharmacogenomic applications:

  • Population variation in TAS2R19 sequence and function

  • Implications for personalized medicine and drug development

  • Potential connections to individual differences in drug efficacy or side effects

These emerging research directions require combining conventional TAS2R19 detection methods with specialized assays for each application domain.

How can advanced technologies enhance TAS2R19 research?

Cutting-edge approaches for TAS2R19 investigation include:

• CRISPR-Cas9 genome editing:

  • Generation of knockout cell lines and animal models

  • Introduction of reporter tags at endogenous loci

  • Creation of specific mutations to study structure-function relationships

• Cryo-electron microscopy:

  • Structural characterization of TAS2R19 alone and in complex with ligands

  • Insights into binding pocket architecture and activation mechanisms

  • Comparison with other GPCR structures

• Organoid technology:

  • Development of taste bud organoids expressing TAS2R19

  • More physiologically relevant model systems

  • Drug screening in 3D culture environments

• Single-cell technologies:

  • Transcript and protein profiling at single-cell resolution

  • Identification of rare cell populations expressing TAS2R19

  • Spatial transcriptomics to map expression patterns in complex tissues

• AI-driven approaches:

  • Computational prediction of TAS2R19 ligands

  • Structure-based virtual screening for novel agonists/antagonists

  • Network analysis integrating multiple data types

These technological advances promise to accelerate discovery and provide deeper insights into TAS2R19 biology and potential therapeutic applications.